Who is sponsoring NCT06126796?

NCT06126796 is sponsored by Mayo Clinic.

What drugs are being tested in NCT06126796?

Interventions in NCT06126796: CxBladder Monitor, Cystoscopy.

What condition does NCT06126796 study?

NCT06126796 studies Non-muscle Invasive Bladder Cancer.

Is NCT06126796 still recruiting?

NCT06126796 is currently completed. Last updated 23 January 2026.

Last reviewed 2026-01-23 · How we verify

NCT06126796

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)

Completed Last updated 23 January 2026

What this trial tests

trial testing CxBladder Monitor in Non-muscle Invasive Bladder Cancer in 107 participants. Completed in 8 September 2025.

Timeline

16 November 2023

Primary endpoint
8 September 2025

8 September 2025

Quick facts

Lead sponsor	Mayo Clinic
Status	Completed
Study type	OBSERVATIONAL
Enrollment	107
Start date	16 November 2023
Primary completion	8 September 2025
Estimated completion	8 September 2025
Sites	1 location across United States

Drugs / interventions tested

CxBladder Monitor
Cystoscopy

Conditions studied

Non-muscle Invasive Bladder Cancer — all drugs for Non-muscle Invasive Bladder Cancer →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Non-muscle Invasive Bladder Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate patient-reported preference for urine based molecular testing (CxBladder Monitor) compared to cystoscopy for patients on surveillance for Nonmuscle Invasive Bladder Cancer (NMIBC). Urine based molecular testing involves noninvasive testing of a urine sample for biomarkers associated with disease recurrence. Cystoscopy is an examination of the bladder and urethra using a thin tube like instrument that is inserted into the urethra.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Urine-Based Approaches for Screening, Diagnosis, and Surveillance of Urothelial Carcinoma.
Bilim V, Hoshi S. · · 2026 · PMID 41893002 · DOI 10.3390/jpm16030135

Verify or expand the search:

Other recruiting trials for Non-muscle Invasive Bladder Cancer

Currently open trials in the same condition.

NCT07206225 — A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer · Phase 1 · recruiting
NCT06503614 — A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer · Phase 2 · recruiting
NCT06632964 — A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder C · Phase 1 · recruiting
NCT07252297 — The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer · NA · active not recruiting
NCT04165317 — A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer · Phase 3 · active not recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06126796 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 23 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06126796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing